BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

648 related articles for article (PubMed ID: 17427549)

  • 1. [Biotypes and antibiotic resistance patterns of Gardnerella vaginalis strains isolated from healthy women and women with bacterial vaginosis].
    Tosun I; Alpay Karaoğlu S; Ciftçi H; Buruk CK; Aydin F; Kiliç AO; Ertürk M
    Mikrobiyol Bul; 2007 Jan; 41(1):21-7. PubMed ID: 17427549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems.
    Aroutcheva AA; Simoes JA; Behbakht K; Faro S
    Clin Infect Dis; 2001 Oct; 33(7):1022-7. PubMed ID: 11528575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A biotype study of Gardnerella vaginalis isolated from patients with and without symptoms of bacterial vaginosis].
    Barberis IL; Pájaro MC; Daniele ML; Godino S; Pascual L
    Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):506-8. PubMed ID: 10650646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility.
    Simoes JA; Aroutcheva A; Heimler I; Shott S; Faro S
    Am J Obstet Gynecol; 2001 Nov; 185(5):1186-90. PubMed ID: 11717655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis].
    Tomusiak A; Strus M; Heczko PB
    Ginekol Pol; 2011 Dec; 82(12):900-4. PubMed ID: 22384625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
    Bradshaw CS; Tabrizi SN; Fairley CK; Morton AN; Rudland E; Garland SM
    J Infect Dis; 2006 Sep; 194(6):828-36. PubMed ID: 16941351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis.
    Nagaraja P
    Indian J Med Microbiol; 2008; 26(2):155-7. PubMed ID: 18445953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gardnerella vaginalis biotypes: modification of a proposed system].
    Pedraza-Avilés AG; Inzunza-Montiel AE; Ortíz-Zaragoza MC; Morales-Espinosa MR; Ponce-Rosas ER
    Rev Latinoam Microbiol; 1995; 37(1):19-26. PubMed ID: 7784728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of main lactobacillus species between healthy women and women with bacterial vaginosis.
    Yan DH; Lü Z; Su JR
    Chin Med J (Engl); 2009 Nov; 122(22):2748-51. PubMed ID: 19951608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis.
    Schuyler JA; Mordechai E; Adelson ME; Sobel JD; Gygax SE; Hilbert DW
    Diagn Microbiol Infect Dis; 2016 Jan; 84(1):1-3. PubMed ID: 26514076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal study of the biotypes of Gardnerella vaginalis.
    Briselden AM; Hillier SL
    J Clin Microbiol; 1990 Dec; 28(12):2761-4. PubMed ID: 2280007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.
    Cavera VL; Volski A; Chikindas ML
    Probiotics Antimicrob Proteins; 2015 Jun; 7(2):164-71. PubMed ID: 25588687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics.
    Simoes JA; Hashemi FB; Aroutcheva AA; Heimler I; Spear GT; Shott S; Faro S
    J Infect Dis; 2001 Jul; 184(1):22-7. PubMed ID: 11398105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
    Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
    J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility and vaginolysin in Gardnerella vaginalis from healthy and bacterial vaginosis diagnosed women.
    Knupp de Souza DM; Diniz CG; Filho DS; Andrade de Oliveira LM; Coelho DM; Talha LS; Nascimento TC; Ferreira-Machado AB; Silva VL
    J Infect Dev Ctries; 2016 Sep; 10(9):913-919. PubMed ID: 27694723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biotypes and virulence factors of Gardnerella vaginalis isolated from cases of bacterial vaginosis.
    Udayalaxmi J; Bhat GK; Kotigadde S
    Indian J Med Microbiol; 2011; 29(2):165-8. PubMed ID: 21654113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of virulence factors & biotypes of
    Nisha K; Antony B; Udayalaxmi J
    Indian J Med Res; 2019 Jan; 149(1):57-61. PubMed ID: 31115376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the anaerobic (bacterial) vaginosis among the Bangladeshi women of reproductive age group.
    Naher A; Rahman KM; Hassan MM; Hoq JA
    Bangladesh Med Res Counc Bull; 1994 Dec; 20(3):129-38. PubMed ID: 7748151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of vaginal bacteria to metronidazole and tinidazole.
    Austin MN; Meyn LA; Hillier SL
    Anaerobe; 2006; 12(5-6):227-30. PubMed ID: 16893662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance associated with the treatment of bacterial vaginosis.
    Beigi RH; Austin MN; Meyn LA; Krohn MA; Hillier SL
    Am J Obstet Gynecol; 2004 Oct; 191(4):1124-9. PubMed ID: 15507930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.